chr22-36922267-C-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000395.3(CSF2RB):c.60C>A(p.Ser20Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000296 in 1,578,894 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000395.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.60C>A | p.Ser20Arg | missense_variant | 2/14 | ENST00000403662.8 | |
LOC105373023 | XR_938230.2 | n.195-3328G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.60C>A | p.Ser20Arg | missense_variant | 2/14 | 5 | NM_000395.3 | P1 | |
CSF2RB | ENST00000406230.5 | c.60C>A | p.Ser20Arg | missense_variant | 1/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152150Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000985 AC: 188AN: 190856Hom.: 0 AF XY: 0.000918 AC XY: 94AN XY: 102398
GnomAD4 exome AF: 0.000289 AC: 412AN: 1426626Hom.: 3 Cov.: 31 AF XY: 0.000266 AC XY: 188AN XY: 706382
GnomAD4 genome AF: 0.000361 AC: 55AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | CSF2RB: BP4, BS1 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
CSF2RB-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at